These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17147869)

  • 21. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.
    Zhou SX; Qiu HB; Huang YZ; Yang Y; Zheng RQ
    Acta Pharmacol Sin; 2002 Jul; 23(7):654-8. PubMed ID: 12100762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norepinephrine in low to moderate doses may not increase luminal concentrations of L-lactate in the gut in patients with septic shock.
    Ibsen M; Jørgensen VL; Perner A
    Acta Anaesthesiol Scand; 2007 Sep; 51(8):1079-84. PubMed ID: 17697303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noradrenaline use for septic shock in children: doses, routes of administration and complications.
    Lampin ME; Rousseaux J; Botte A; Sadik A; Cremer R; Leclerc F
    Acta Paediatr; 2012 Sep; 101(9):e426-30. PubMed ID: 22568565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL; Walley KR
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and exclusive use of norepinephrine in septic shock.
    Morimatsu H; Singh K; Uchino S; Bellomo R; Hart G
    Resuscitation; 2004 Aug; 62(2):249-54. PubMed ID: 15294412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of heptaminol hydrochloride for catecholamine weaning in septic shock.
    Bahloul M; Chaari A; Ben Mbarek MN; Kallel H; Bouaziz M
    Am J Ther; 2012 Jan; 19(1):e8-17. PubMed ID: 20720484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressor and inotropic support in septic shock: an evidence-based review.
    Beale RJ; Hollenberg SM; Vincent JL; Parrillo JE
    Crit Care Med; 2004 Nov; 32(11 Suppl):S455-65. PubMed ID: 15542956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early suspension of activated protein C treatment in septic patients after shock reversal.
    Pestaña D; Ramos R
    Eur J Anaesthesiol; 2009 Dec; 26(12):1072-5. PubMed ID: 19474736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 31. [Systemic hemodynamics in constant hemofiltration in patients with septic shock].
    Iakovleva II; Timokhov VS; Pestriakov EV; Moroz VV; Murav'ev OB; Sergeev AIu
    Anesteziol Reanimatol; 2002; (2):63-6. PubMed ID: 12227004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evidence-based resuscitation algorithm applied from the emergency room to the ICU improves survival of severe septic shock.
    Castro R; Regueira T; Aguirre ML; Llanos OP; Bruhn A; Bugedo G; Dougnac A; Castillo L; Andresen M; Hernández G
    Minerva Anestesiol; 2008 Jun; 74(6):223-31. PubMed ID: 18356807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of early oral fluid resuscitation on organ functions and survival during shock stage in dogs with a 50% total body surface area full-thickness burn].
    Hu S; Che JW; Wang HB; Yu Y; Tian YJ; Sheng ZY
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3149-52. PubMed ID: 19159601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-abdominal hypertension: incidence and association with organ dysfunction during early septic shock.
    Regueira T; Bruhn A; Hasbun P; Aguirre M; Romero C; Llanos O; Castro R; Bugedo G; Hernandez G
    J Crit Care; 2008 Dec; 23(4):461-7. PubMed ID: 19056007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noradrenaline as a vasoactive agent in septic shock.
    Tordoff SG; Thompson JL; Williams AW
    Intensive Care Med; 2000 May; 26(5):648. PubMed ID: 10923747
    [No Abstract]   [Full Text] [Related]  

  • 39. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock.
    Boussekey N; Chiche A; Faure K; Devos P; Guery B; d'Escrivan T; Georges H; Leroy O
    Intensive Care Med; 2008 Sep; 34(9):1646-53. PubMed ID: 18542921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: a crossover pilot study.
    Morelli A; Lange M; Ertmer C; Dünser M; Rehberg S; Bachetoni A; D'Alessandro M; Van Aken H; Guarracino F; Pietropaoli P; Traber DL; Westphal M
    Shock; 2008 Apr; 29(4):446-51. PubMed ID: 17885646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.